Here's the live share price of Acutaas Chemicals along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Over the last 5 years, the share price of Acutaas Chemicals has gained 28.70% CAGR. Over the past year, the corresponding return has been 106.83%.
Acutaas Chemicals’s current P/E of 71.45x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Highest YOY Quarterly profit growth Screener.
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
---|---|---|---|---|---|---|---|
Acutaas Chemicals | 12.46 | 12.07 | 36.60 | 42.02 | 106.83 | 51.86 | 28.70 |
Sun Pharmaceutical Industries | 0.61 | 3.75 | -1.31 | -4.00 | -11.06 | 19.71 | 28.30 |
Divi's Laboratories | 1.82 | 9.01 | -2.79 | 16.99 | 8.54 | 22.59 | 16.36 |
Cipla | 0.74 | 0.89 | 6.11 | 3.80 | 0.95 | 12.39 | 15.54 |
Torrent Pharmaceuticals | 0.79 | 0.61 | 1.73 | 9.53 | 4.97 | 31.14 | 21.67 |
Dr. Reddy's Laboratories | -0.59 | -4.09 | -0.47 | 8.04 | -6.16 | 13.20 | 4.47 |
Mankind Pharma | 0.79 | -3.52 | -6.15 | -4.04 | -7.61 | 20.31 | 11.73 |
Zydus Lifesciences | -0.62 | -4.59 | 0.54 | 18.75 | -3.29 | 33.06 | 18.48 |
Lupin | -1.21 | -4.69 | -0.99 | -0.04 | -11.08 | 40.99 | 13.81 |
Alkem Laboratories | 2.52 | 2.09 | 11.49 | 12.91 | -7.17 | 21.39 | 16.09 |
Aurobindo Pharma | -2.60 | 0.45 | -4.57 | -6.04 | -25.00 | 28.42 | 6.59 |
Abbott India | -1.13 | -3.60 | -12.58 | -2.76 | 4.99 | 18.17 | 13.51 |
Glenmark Pharmaceuticals | -3.81 | -8.65 | -16.23 | 39.03 | 7.51 | 67.86 | 31.37 |
Laurus Labs | 2.78 | 0.87 | 9.70 | 43.66 | 93.21 | 20.69 | 22.11 |
Biocon | 0.60 | 0.17 | -10.55 | 7.19 | 4.69 | 10.42 | -4.10 |
GlaxoSmithKline Pharmaceuticals | -0.62 | 0.42 | -13.35 | -5.58 | 3.60 | 26.00 | 12.58 |
Anthem Biosciences | -5.27 | -12.22 | 3.79 | 3.79 | 3.79 | 1.25 | 0.75 |
Cohance Lifesciences | -1.85 | -8.23 | -18.75 | -23.96 | -28.98 | 31.15 | 21.02 |
Ipca Laboratories | -3.35 | -1.70 | -12.53 | -7.89 | -21.82 | 13.02 | 4.25 |
Gland Pharma | 0.74 | -2.60 | -3.58 | 33.69 | 18.08 | -3.50 | 1.24 |
Over the last one year, Acutaas Chemicals has gained 106.83% compared to peers like Sun Pharmaceutical Industries (-11.06%), Divi's Laboratories (8.54%), Cipla (0.95%). From a 5 year perspective, Acutaas Chemicals has outperformed peers relative to Sun Pharmaceutical Industries (28.30%) and Divi's Laboratories (16.36%).
Day | SMA | EMA |
---|---|---|
5 | 1,485.66 | 1,512 |
10 | 1,440.51 | 1,477.01 |
20 | 1,430.05 | 1,449.81 |
50 | 1,406.91 | 1,396.09 |
100 | 1,277.26 | 1,319.97 |
200 | 1,204.8 | 1,207.22 |
In the latest quarter, Acutaas Chemicals remained same as its previous close in promoter holding, while DII stake increased to 22.59%, FII holding fell to 16.84%, and public shareholding moved down to 27.89% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
---|---|---|---|
20,00,000 | 0.77 | 263.56 | |
9,00,000 | 3.02 | 118.6 | |
4,34,420 | 1.26 | 57.25 | |
3,90,000 | 0.29 | 51.39 | |
3,60,154 | 2.77 | 47.46 | |
2,97,588 | 0.59 | 39.22 | |
2,87,559 | 2.58 | 37.89 | |
2,85,350 | 2.74 | 37.6 | |
1,25,625 | 2.67 | 16.55 | |
89,224 | 1.07 | 11.76 |
* Excluding Index & Arbitrage Funds
Date Time | Announcement |
---|---|
Oct 17, 2025, 11:49 PM IST | Acutaas Chemicals - Recording Of Earnings Conference Call Held On October 17, 2025 |
Oct 17, 2025, 5:26 PM IST | Acutaas Chemicals - Board Meeting Outcome for Outcome Of Board Meeting Held On October 17, 2025 |
Oct 17, 2025, 5:56 AM IST | Acutaas Chemicals - Announcement under Regulation 30 (LODR)-Press Release / Media Release |
Oct 17, 2025, 5:53 AM IST | Acutaas Chemicals - Announcement under Regulation 30 (LODR)-Investor Presentation |
Oct 17, 2025, 5:31 AM IST | Acutaas Chemicals - Unaudited Standalone And Consolidated Financial Results For Second Quarter And Half Year Ended September |
Acutaas Chemicals Ltd. is a Public Limited Listed company incorporated on 12/06/2007 and has its registered office in the State of Gujarat, India. Company's Corporate Identification Number(CIN) is L24100GJ2007PLC051093 and registration number is 051093. Currently Company is involved in the business activities of Manufacture of organic and inorganic chemical compounds. Company's Total Operating Revenue is Rs. 989.83 Cr. and Equity Capital is Rs. 40.93 Cr. for the Year ended 31/03/2025.
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Acutaas Chemicals is ₹1,650.00 as on Oct 17, 2025.
The Acutaas Chemicals is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
The market cap of Acutaas Chemicals is ₹13,508.74 Cr as on Oct 17, 2025.
Today’s highest and lowest price of Acutaas Chemicals are ₹1,665.00 and ₹1,545.05.
The 52-week high/low is the highest and lowest price at which Acutaas Chemicals stock has traded in the past 52-week or nearly a year. The 52-week high of Acutaas Chemicals is ₹1,665.00 and 52-week low of Acutaas Chemicals is ₹727.50 as on Oct 17, 2025.
The Acutaas Chemicals has shown returns of 6.3% over the past day, 12.07% for the past month, 36.6% over 3 months, 106.83% over 1 year, 51.86% across 3 years, and 28.7% over 5 years.
P/E ratio of and PB ratio of Acutaas Chemicals are 71.45 and 11.24 on Oct 17, 2025. While the company gives a dividend yield of 0.00 per annum.